Cell Culture Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI3934
Cell Culture Market size is projected to experience significant growth from 2019 to 2025.
Growing demand for monoclonal antibodies, rising focus on personalized medicines, and increasing funding for cell-based research are some of the factors that is boosting the demand for the cell culture market. The rising awareness pertinent to the benefits of cell culture-based vaccines have boosted the growth of the market. For instance, the U.S. government has invested billions of dollars to develop new manufacturing technologies to produce more vaccines rapidly. In 2016, FDA approved the usage of cell isolated vaccine viruses for the production of flucelvax. Thus, the growing adoption of cell culture-based vaccines in order to treat diseases is driving the growth of the market.
Rising awareness among physicians and patients pertaining to the applications of monoclonal antibody therapies are further contributing to the growth of the market. Most innovative biologic medicines available in the market have been monoclonal antibodies which is continuing to develop for prophylaxis and treatment of a variety of diseases. For instance, GlaxoSmithKline’s Abthrax given for the prevention and treatment of inhalation Anthrax is the only monoclonal antibody available in the market. Monoclonal antibodies for the treatment and prevention of infectious diseases including bacterial and viral infections are boosting the growth of the market.
Growing incidence of chronic diseases have led to increase in cytological studies, cell biology and associated research resulting in the growth of cell culture market. Furthermore, increase in the number of research projects pertinent to cancer and higher applications of gene therapies are some of the factors that is anticipated to drive the demand in the market over the upcoming years
However, some of the factors such as solid regulatory framework imposition and high standard quality set by leaders of the market may act as an impediment to the overall growth of the market in the future years. Strict regulations are further projected to restrict the market growth.
Consumables segment is dominating the cell culture market. This is attributed to various factors such as constant purchase of reagents, media for various cell culture applications such as vaccine production, toxicology & drug discovery, and biopharmaceutical production. This in turn is driving the growth of the segment.
Stem cell segment is expected to witness the lucrative growth over the forecast period. This is attributed to the growing demand for stem cell therapy in order to treat various disorders including hematopoietic disorders. Continuous research on exploiting the full potential of stem cells proves to be one of the driving factors for the growth of the market segment.
North America is currently dominating the cell culture market and is attributed to few factors such as rising growth in pharmaceutical and biotechnology industry, rapid technological advancements and strong regulatory approvals for cell culture-based vaccines. Furthermore, growing demand for cell culture-based vaccines in diseases like cancer is also boosting the growth of the market in the region.
Asia pacific is expected to witness the lucrative growth over the forecast period. Key factors such as launch of advanced cell culture products, and rising awareness about the benefits of cell culture-based vaccines is expected to drive the growth of the market in the region in the upcoming years.
Few of the key companies operating in cell culture market include BD, Thermo Fisher Scientific, HiMedia Laboratories, GE Healthcare, Lonza, Corning, Sartorious AG, Promo cell Gmbh and others. Various pharmaceutical companies are focusing on mergers and acquisitions with biotechnology companies to expand their product portfolios and reinforce their market position.
Cell Culture Market by Product, 2014-2025 (USD Million)
Cell Culture Market by Application, 2014-2025 (USD Million)
- Stem cell
- Therapeutic proteins
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- BD (Becton & Dickinson)
- Thermo Fisher Scientific
- HiMedia Laboratories
- GE Healthcare
- Sartorius AG
- PromoCell GmbH
- FUJIFILM Irvine Scientific
- Teleflex Incorporated
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.